Systemic Psoriasis Therapeutics

Systemic Psoriasis Therapeutics

Global Systemic Psoriasis Therapeutics Market to Reach $19.1 Billion by 2027

Amid the COVID-19 crisis, the global market for Systemic Psoriasis Therapeutics estimated at US$10.7 Billion in the year 2020, is projected to reach a revised size of US$19.1 Billion by 2027, growing at a CAGR of 8.6% over the period 2020-2027.

The U.S. Market is Estimated at $3.2 Billion, While China is Forecast to Grow at 8% CAGR

The Systemic Psoriasis Therapeutics market in the U.S. is estimated at US$3.2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.3 Billion by the year 2027 trailing a CAGR of 8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8% and 7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7% CAGR.

Select Competitors (Total 38 Featured) -

  • AbbVie Inc.
  • Amgen Inc.
  • Biogen Idec
  • Celgene Corporation
  • Eli Lilly and Company
  • Janssen Biotech, Inc.
  • Novartis AG
  • Pfizer Inc.
  • Stiefel Laboratories, Inc.
  • Takeda Pharmaceutical Company Limited
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Current & Future Analysis for Systemic Psoriasis Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 2: World Historic Review for Systemic Psoriasis Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 3: World 15-Year Perspective for Systemic Psoriasis Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
III. MARKET ANALYSIS
UNITED STATES
TABLE 4: USA Current & Future Analysis for Systemic Psoriasis Therapeutics by Segment - Systemic Psoriasis Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 5: USA Historic Review for Systemic Psoriasis Therapeutics by Segment - Systemic Psoriasis Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
CANADA
TABLE 6: Canada Current & Future Analysis for Systemic Psoriasis Therapeutics by Segment - Systemic Psoriasis Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 7: Canada Historic Review for Systemic Psoriasis Therapeutics by Segment - Systemic Psoriasis Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
JAPAN
TABLE 8: Japan Current & Future Analysis for Systemic Psoriasis Therapeutics by Segment - Systemic Psoriasis Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 9: Japan Historic Review for Systemic Psoriasis Therapeutics by Segment - Systemic Psoriasis Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
CHINA
TABLE 10: China Current & Future Analysis for Systemic Psoriasis Therapeutics by Segment - Systemic Psoriasis Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 11: China Historic Review for Systemic Psoriasis Therapeutics by Segment - Systemic Psoriasis Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
EUROPE
TABLE 12: Europe Current & Future Analysis for Systemic Psoriasis Therapeutics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 13: Europe Historic Review for Systemic Psoriasis Therapeutics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 14: Europe 15-Year Perspective for Systemic Psoriasis Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
FRANCE
TABLE 15: France Current & Future Analysis for Systemic Psoriasis Therapeutics by Segment - Systemic Psoriasis Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 16: France Historic Review for Systemic Psoriasis Therapeutics by Segment - Systemic Psoriasis Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
GERMANY
TABLE 17: Germany Current & Future Analysis for Systemic Psoriasis Therapeutics by Segment - Systemic Psoriasis Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 18: Germany Historic Review for Systemic Psoriasis Therapeutics by Segment - Systemic Psoriasis Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
ITALY
TABLE 19: Italy Current & Future Analysis for Systemic Psoriasis Therapeutics by Segment - Systemic Psoriasis Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 20: Italy Historic Review for Systemic Psoriasis Therapeutics by Segment - Systemic Psoriasis Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UNITED KINGDOM
TABLE 21: UK Current & Future Analysis for Systemic Psoriasis Therapeutics by Segment - Systemic Psoriasis Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 22: UK Historic Review for Systemic Psoriasis Therapeutics by Segment - Systemic Psoriasis Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
REST OF EUROPE
TABLE 23: Rest of Europe Current & Future Analysis for Systemic Psoriasis Therapeutics by Segment - Systemic Psoriasis Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 24: Rest of Europe Historic Review for Systemic Psoriasis Therapeutics by Segment - Systemic Psoriasis Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
ASIA-PACIFIC
TABLE 25: Asia-Pacific Current & Future Analysis for Systemic Psoriasis Therapeutics by Segment - Systemic Psoriasis Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 26: Asia-Pacific Historic Review for Systemic Psoriasis Therapeutics by Segment - Systemic Psoriasis Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
REST OF WORLD
TABLE 27: Rest of World Current & Future Analysis for Systemic Psoriasis Therapeutics by Segment - Systemic Psoriasis Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 28: Rest of World Historic Review for Systemic Psoriasis Therapeutics by Segment - Systemic Psoriasis Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
IV. COMPETITION
Total Companies Profiled: 38

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook